Why the study?
Do ACE inhibitors reduce mortality, morbidity, and symptoms in patients with left ventricular dysfunction and congestive heart failure?
Do ACE inhibitors reduce mortality, morbidity, and symptoms in patients with left ventricular dysfunction and congestive heart failure?
Routine use of ACE inhibitors is recommended as early as possible in patients with left ventricular dysfunction to improve survival and reduce hospitalizations and costs.
No takes yet. Share an insight, caveat, or question.
Supports early ACE inhibitor use in LV dysfunction; leaves open optimal sequencing with modern therapies.
McKelvie et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: